About Us
Contact Us
Hua Mu, M.D., Ph.D., Chief Scientific Officer
Dr. Mu is in charge of scientific and medical affairs at Simcere Pharma and directly runs the Institute of Clinical Research and Development. He received his medical degree from West China Medical Center, Sichuan University and Ph.D. degree in genetic epidemiology from University of California at Berkeley, under the mentorship of Dr. Mary-Claire King (the discoverer of breast cancer gene BRCA1). He did post-doctoral clinical and translational research at UCSF School of Medicine and University of Washington School of Medicine. Dr. Mu held leadership positions at multiple global pharmaceutical and biotech companies including Roche, BiogenIndec, Genentech and Hutchison Medi Pharma. He participated in and led nearly 20 R&D projects of both small molecule drugs and biologics, including the successful global development and product launch of anti-cancer drugs Xeloda, Abraxane and Avastin. Prior to joining Simcere, Dr. Mu was the Senior Vice President and Global Head of Product Development Service and Partnership at Wuxi AppTec, responsible for integrated product development service and strategic collaboration.
© Copyright 2016 www.simcere.com All Rights Reserved.